PI Health Sciences

PI Health Sciences, established in 1946, operates as a prominent Contract Research, Development, and Manufacturing Organization (CRDMO) within the Pharmaceutical and Healthcare sectors. The company provides comprehensive, end-to-end solutions that span the entire lifecycle from drug discovery through development and into manufacturing. This integrated approach serves both large pharmaceutical corporations and agile biotech partners, positioning PI Health Sciences as a critical enabler in the drug development pipeline. Its strategic focus on innovation and quality underpins its service offerings, aiming to accelerate the journey of novel therapeutics to market. The company's commitment to scientific rigor is evident in its operational framework, designed to meet the complex demands of its clientele.

With a significant operational footprint, PI Health Sciences maintains R&D and manufacturing facilities across Europe, specifically in Italy, and multiple sites in India, including Hyderabad, Panoli, Jaipur, and Ankleshwar. This distributed network allows for specialized capabilities and efficient production scaling. The company employs between 500 - 1,000 professionals dedicated to advancing research and manufacturing excellence. Meet PI Health Sciences' team to understand the expertise driving these operations. The strategic placement of these facilities ensures robust supply chain management and the capacity to handle diverse project requirements, from early-stage research to commercial-scale manufacturing.

PI Health Sciences generates substantial revenue, reporting $107.8M, reflecting its market position and the demand for its specialized CRDMO services. Its presence in India and Asia, alongside its European operations, highlights a global outlook and capability to serve international markets. The company's hashtags, such as #india and #asiapacific, further emphasize itsView more...